These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 30383930)
1. [FIBROBLAST ACTIVATION PROTEIN (FAP) AS A POSSIBLE TARGET OF THE ANTITUMOR STRATEGY.]. Pleshkan VV; Alekseenko IV; Tyulkina DV; Kyzmich AI; Zinovyeva MV; Sverdlov ED Mol Gen Mikrobiol Virusol; 2016; 34(3):90-97. PubMed ID: 30383930 [TBL] [Abstract][Full Text] [Related]
2. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma. Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457 [TBL] [Abstract][Full Text] [Related]
3. Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells. Lai D; Ma L; Wang F Int J Oncol; 2012 Aug; 41(2):541-50. PubMed ID: 22614695 [TBL] [Abstract][Full Text] [Related]
4. Effects of the fibroblast activation protein on the invasion and migration of gastric cancer. Wang RF; Zhang LH; Shan LH; Sun WG; Chai CC; Wu HM; Ibla JC; Wang LF; Liu JR Exp Mol Pathol; 2013 Dec; 95(3):350-56. PubMed ID: 24422232 [TBL] [Abstract][Full Text] [Related]
5. The application of the fibroblast activation protein α-targeted immunotherapy strategy. Jiang GM; Xu W; Du J; Zhang KS; Zhang QG; Wang XW; Liu ZG; Liu SQ; Xie WY; Liu HF; Liu JS; Wu BP Oncotarget; 2016 May; 7(22):33472-82. PubMed ID: 26985769 [TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma. Kakarla S; Chow KK; Mata M; Shaffer DR; Song XT; Wu MF; Liu H; Wang LL; Rowley DR; Pfizenmaier K; Gottschalk S Mol Ther; 2013 Aug; 21(8):1611-20. PubMed ID: 23732988 [TBL] [Abstract][Full Text] [Related]
7. Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin. LeBeau AM; Brennen WN; Aggarwal S; Denmeade SR Mol Cancer Ther; 2009 May; 8(5):1378-86. PubMed ID: 19417147 [TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro. Teichgräber V; Monasterio C; Chaitanya K; Boger R; Gordon K; Dieterle T; Jäger D; Bauer S Adv Med Sci; 2015 Sep; 60(2):264-72. PubMed ID: 26057860 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer. Sandberg TP; Stuart MPME; Oosting J; Tollenaar RAEM; Sier CFM; Mesker WE BMC Cancer; 2019 Mar; 19(1):284. PubMed ID: 30922247 [TBL] [Abstract][Full Text] [Related]
10. Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase? Juillerat-Jeanneret L; Tafelmeyer P; Golshayan D Expert Opin Ther Targets; 2017 Oct; 21(10):977-991. PubMed ID: 28829211 [TBL] [Abstract][Full Text] [Related]
11. Targeting fibroblast activation protein in cancer - Prospects and caveats. Busek P; Mateu R; Zubal M; Kotackova L; Sedo A Front Biosci (Landmark Ed); 2018 Jun; 23(10):1933-1968. PubMed ID: 29772538 [TBL] [Abstract][Full Text] [Related]
12. Fibroblast activation protein in remodeling tissues. Jacob M; Chang L; Puré E Curr Mol Med; 2012 Dec; 12(10):1220-43. PubMed ID: 22834826 [TBL] [Abstract][Full Text] [Related]
13. Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications. Šimková A; Bušek P; Šedo A; Konvalinka J Biochim Biophys Acta Proteins Proteom; 2020 Jul; 1868(7):140409. PubMed ID: 32171757 [TBL] [Abstract][Full Text] [Related]
14. Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy. Kraxner A; Braun F; Cheng WY; Yang TO; Pipaliya S; Canamero M; Andersson E; Harring SV; Dziadek S; Bröske AE; Ceppi M; Tanos T; Teichgräber V; Charo J Front Immunol; 2024; 15():1352632. PubMed ID: 39035007 [TBL] [Abstract][Full Text] [Related]
15. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug. Brennen WN; Rosen DM; Wang H; Isaacs JT; Denmeade SR J Natl Cancer Inst; 2012 Sep; 104(17):1320-34. PubMed ID: 22911669 [TBL] [Abstract][Full Text] [Related]
16. Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions. Huang Y; Simms AE; Mazur A; Wang S; León NR; Jones B; Aziz N; Kelly T Clin Exp Metastasis; 2011 Aug; 28(6):567-79. PubMed ID: 21604185 [TBL] [Abstract][Full Text] [Related]
17. Selective Activation of Anticancer Chemotherapy by Cancer-Associated Fibroblasts in the Tumor Microenvironment. Kim MG; Shon Y; Kim J; Oh YK J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27615014 [TBL] [Abstract][Full Text] [Related]
18. Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review). Zi F; He J; He D; Li Y; Yang L; Cai Z Mol Med Rep; 2015 May; 11(5):3203-11. PubMed ID: 25593080 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option. Dienus K; Bayat A; Gilmore BF; Seifert O Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224 [TBL] [Abstract][Full Text] [Related]
20. Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody-Drug Conjugate Targeting Fibroblast Activation Protein. Gallant JP; Hintz HM; Gunaratne GS; Breneman MT; Recchia EE; West JL; Ott KL; Heninger E; Jackson AE; Luo NY; Rosenkrans ZT; Hernandez R; Zhao SG; Lang JM; Meimetis L; Kosoff D; LeBeau AM Cancer Res Commun; 2024 Jun; 4(6):1481-1494. PubMed ID: 38747612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]